Literature DB >> 10025921

Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes.

M Kuwana1, Y Okano, J Kaburaki, T A Medsger, T M Wright.   

Abstract

OBJECTIVE: To determine the subunit specificity of autoantibody directed to RNA polymerases (RNAP) I, II, and III, which is one of the major autoantibody responses in patients with systemic sclerosis (SSc).
METHODS: Thirty-two SSc sera with anti-RNAP antibodies (23 with anti-RNAP I/III, 5 with anti-RNAP I/III and II, and 4 with anti-RNAP II alone) were analyzed by immunoblotting using affinity-purified RNAP and by immunoprecipitation using 35S-labeled cell extracts in which RNAP complexes were dissociated. Antibodies bound to individual RNAP subunits were eluted from preparative immunoblots and were further analyzed by immunoblotting and immunoprecipitation.
RESULTS: At least 15 different proteins were bound by antibodies in anti-RNAP-positive SSc sera in various combinations. All 9 sera immunoprecipitating RNAP II and all 28 sera immunoprecipitating RNAP I/III recognized the large subunit proteins of RNAP II and III, respectively. Reactivity to RNAP I large subunits was strongly associated with bright nucleolar staining by indirect immunofluorescence. Affinity-purified antibodies that recognized a 62-kd subunit protein cross-reacted with a 43-kd subunit protein and immunoprecipitated both RNAP I and RNAP III. Antibodies that recognized a 21-kd subunit protein obtained from sera that were positive for anti-RNAP I/III and II antibodies immunoprecipitated both RNAP II and RNAP III.
CONCLUSION: Anti-RNAP antibodies recognize multiple subunits of RNAP I, II, and III. Moreover, the results of this study provide the first direct evidence that antibodies that recognize shared subunits of human RNAPs or epitopes present on different human RNAP subunits are responsible for the recognition of multiple RNAPs by SSc sera.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025921     DOI: 10.1002/1529-0131(199902)42:2<275::AID-ANR9>3.0.CO;2-P

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Systemic sclerosis: an autoantibody mosaic.

Authors:  C C Bunn; C M Black
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.

Authors:  Noreen Fertig; Robyn T Domsic; Tatiana Rodriguez-Reyna; Masataka Kuwana; Mary Lucas; Thomas A Medsger; Carol A Feghali-Bostwick
Journal:  Arthritis Rheum       Date:  2009-07-15

3.  Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma.

Authors:  Ami A Shah; Marikki Laiho; Antony Rosen; Livia Casciola-Rosen
Journal:  Arthritis Rheumatol       Date:  2019-08-01       Impact factor: 10.995

4.  B cell block: is rituximab a new possible treatment for systemic sclerosis?

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2010-11-20       Impact factor: 5.782

5.  Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.

Authors:  G R Harvey; S Butts; A L Rands; Y Patel; N J McHugh
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.

Authors:  Ilaria Cavazzana; Tamara Vojinovic; Paolo Airo'; Micaela Fredi; Angela Ceribelli; Eleonora Pedretti; Maria Grazia Lazzaroni; Emirena Garrafa; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

Review 7.  Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen.

Authors:  Maria-Grazia Lazzaroni; Paolo Airò
Journal:  J Scleroderma Relat Disord       Date:  2018-07-13

Review 8.  Anti-nuclear autoantibodies in systemic sclerosis : News and perspectives.

Authors:  Yasuhito Hamaguchi; Kazuhiko Takehara
Journal:  J Scleroderma Relat Disord       Date:  2018-07-10

Review 9.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.